respiratori
viru
infect
one
major
sourc
exacerb
chronic
airway
inflammatori
diseas
exacerb
associ
high
morbid
even
mortal
worldwid
current
understand
viralinduc
exacerb
viral
infect
increas
airway
inflamm
aggrav
diseas
symptom
recent
advanc
vitro
airliquid
interfac
cultur
organoid
cultur
use
novel
human
anim
challeng
model
evok
new
understand
mechan
viral
exacerb
review
focu
recent
novel
find
elucid
respiratori
viral
infect
alter
epitheli
barrier
airway
upper
airway
microbi
environ
epigenet
modif
includ
mirna
modul
chang
immun
respons
throughout
upper
lower
airway
first
review
preval
differ
respiratori
viral
infect
caus
exacerb
chronic
airway
inflammatori
diseas
subsequ
also
summar
recent
model
expand
appreci
mechan
viralinduc
exacerb
highlight
import
virom
within
airway
microbiom
environ
impact
subsequ
bacteri
infect
review
consolid
understand
viral
induc
exacerb
chronic
airway
inflammatori
diseas
indic
pathway
may
target
effect
manag
chronic
inflammatori
diseas
preval
chronic
airway
inflammatori
diseas
increas
worldwid
especi
develop
nation
gbd
chronic
respiratori
diseas
collabor
guan
et
al
diseas
character
airway
inflamm
lead
complic
cough
wheez
short
breath
diseas
manifest
upper
airway
chronic
rhinosinus
cr
lower
airway
asthma
chronic
obstruct
pulmonari
diseas
copd
greatli
affect
patient
qualiti
life
calu
et
al
bao
et
al
treatment
manag
vari
greatli
efficaci
due
complex
heterogen
diseas
complic
effect
episod
exacerb
diseas
defin
worsen
diseas
symptom
includ
wheez
cough
breathless
chest
tight
xepapadaki
papadopoulo
exacerb
due
effect
enhanc
acut
airway
inflamm
impact
upon
worsen
symptom
exist
diseas
hashimoto
et
al
viniol
vogelmei
acut
exacerb
main
caus
morbid
sometim
mortal
patient
well
result
major
econom
burden
worldwid
howev
due
complex
interact
host
exacerb
agent
mechan
exacerb
may
vari
consider
differ
individu
variou
trigger
acut
exacerb
usual
due
presenc
environment
factor
allergen
pollut
smoke
cold
dri
air
pathogen
microb
airway
gautier
charpin
viniol
vogelmei
agent
elicit
immun
respons
lead
infiltr
activ
immun
cell
releas
inflammatori
mediat
caus
acut
symptom
increas
mucu
product
cough
wheez
short
breath
among
agent
viral
infect
one
major
driver
asthma
exacerb
account
exacerb
children
adult
respect
grissel
et
al
xepapadaki
papadopoulo
jartti
gern
ade
et
al
viral
involv
copd
exacerb
also
equal
high
detect
acut
copd
exacerb
kherad
et
al
jafarinejad
et
al
stolz
et
al
whilst
preval
viral
exacerb
cr
still
unclear
preval
like
high
due
similar
inflammatori
natur
diseas
rowan
et
al
tan
et
al
one
reason
involv
respiratori
virus
exacerb
eas
transmiss
infect
kutter
et
al
addit
high
divers
respiratori
virus
may
also
contribut
exacerb
differ
natur
sever
buss
et
al
costa
et
al
jartti
gern
henc
import
identifi
exact
mechan
underpin
viral
exacerb
suscept
subject
order
properli
manag
exacerb
via
supplementari
treatment
may
allevi
exacerb
symptom
prevent
sever
exacerb
lower
airway
site
dysregul
inflamm
chronic
airway
inflammatori
diseas
upper
airway
remain
first
point
contact
sourc
exacerb
therefor
interact
exacerb
agent
may
directli
contribut
subsequ
respons
lower
airway
line
unit
airway
hypothesi
elucid
host
airway
interact
virus
lead
exacerb
thu
focu
review
recent
find
viral
interact
upper
airway
compil
viral
induc
chang
upper
airway
may
contribut
chronic
airway
inflammatori
diseas
exacerb
provid
unifi
elucid
potenti
exacerb
mechan
initi
predominantli
upper
airway
infect
despit
major
caus
exacerb
report
link
respiratori
virus
acut
exacerb
start
emerg
late
pattemor
et
al
bacteri
infect
previous
consid
like
culprit
acut
exacerb
steven
messag
johnston
howev
advent
pcr
technolog
virus
recov
acut
exacerb
event
report
implic
role
emerg
late
messag
johnston
rhinoviru
rv
respiratori
syncyti
viru
rsv
predomin
virus
link
develop
exacerb
chronic
airway
inflammatori
diseas
jartti
gern
virus
parainfluenza
viru
piv
influenza
viru
ifv
adenoviru
adv
also
implic
acut
exacerb
much
lesser
extent
johnston
et
al
oliv
et
al
ko
et
al
recent
virus
includ
bocaviru
bov
human
metapneumoviru
hmpv
certain
coronaviru
cov
strain
specif
enteroviru
ev
strain
human
cytomegaloviru
hcmv
herp
simplex
viru
hsv
report
contribut
acut
exacerb
common
featur
virus
share
infect
upper
andor
lower
airway
increas
inflammatori
condit
diseas
airway
mallia
johnston
britto
et
al
respiratori
virus
primarili
infect
replic
within
airway
epitheli
cell
replic
process
cell
releas
antivir
factor
cytokin
alter
local
airway
inflamm
airway
nich
buss
et
al
healthi
airway
inflamm
normal
lead
type
inflammatori
respons
consist
activ
antivir
state
infiltr
antivir
effector
cell
eventu
result
resolut
inflammatori
respons
clearanc
viral
infect
vareil
et
al
bracial
et
al
howev
chronic
inflam
airway
respons
viru
may
impair
aberr
caus
sustain
inflamm
erron
infiltr
result
exacerb
symptom
mallia
johnston
dougherti
fahi
buss
et
al
britto
et
al
linden
et
al
usual
compound
increas
suscept
chronic
airway
inflammatori
diseas
patient
toward
viral
respiratori
infect
therebi
increas
frequenc
exacerb
whole
dougherti
fahi
buss
et
al
linden
et
al
furthermor
due
differ
replic
cycl
respons
myriad
respiratori
virus
respiratori
viru
may
also
contribut
exacerb
via
differ
mechan
may
alter
sever
henc
review
focu
compil
collat
current
known
mechan
viralinduc
exacerb
chronic
airway
inflammatori
diseas
well
link
differ
viral
infect
pathogenesi
elucid
potenti
way
infect
exacerb
diseas
review
serv
provid
understand
viral
induc
exacerb
identifi
potenti
pathway
pathogenesi
mechan
may
target
supplementari
care
manag
prevent
exacerb
approach
may
clinic
signific
due
current
scarciti
antivir
drug
manag
viralinduc
exacerb
improv
qualiti
life
patient
chronic
airway
inflammatori
diseas
link
viral
infect
acut
exacerb
chronic
airway
inflammatori
diseas
establish
mani
report
mechan
underli
exacerb
induc
respiratori
viral
infect
upon
infect
host
virus
evok
inflammatori
respons
mean
counteract
infect
gener
infect
airway
epitheli
cell
releas
type
type
iii
interferon
cytokin
chemokin
rant
macrophag
inflammatori
protein
monocyt
chemotact
protein
wark
gibson
matsukura
et
al
turn
enabl
infiltr
innat
immun
cell
profession
antigen
present
cell
apc
turn
releas
specif
mediat
facilit
viral
target
clearanc
includ
type
ii
interferon
wark
gibson
singh
et
al
bracial
et
al
factor
heighten
local
inflamm
infiltr
granulocyt
tcell
bcell
wark
gibson
bracial
et
al
increas
inflamm
turn
worsen
symptom
airway
diseas
addit
patient
asthma
patient
cr
nasal
polyp
crswnp
viral
infect
rv
rsv
promot
type
immun
respons
becker
jackson
et
al
jurak
et
al
amplifi
basal
type
inflamm
result
greater
releas
rant
eotaxin
increas
eosinophilia
key
patholog
driver
asthma
crswnp
wark
gibson
singh
et
al
chung
et
al
dunican
fahi
increas
eosinophilia
turn
worsen
classic
symptom
diseas
may
lead
lifethreaten
condit
due
breath
difficulti
hand
patient
copd
patient
cr
without
nasal
polyp
crssnp
neutrophil
natur
due
express
neutrophil
chemoattract
cukic
et
al
brightl
green
patholog
airway
diseas
character
airway
remodel
due
presenc
remodel
factor
matrix
metalloproteinas
mmp
releas
infiltr
neutrophil
linden
et
al
viral
infect
condit
caus
increas
neutrophil
activ
worsen
symptom
airway
remodel
airway
therebi
exacerb
copd
crssnp
even
crswnp
certain
case
wang
et
al
tacon
et
al
linden
et
al
epithelialcentr
alarmin
pathway
around
thymic
stromal
lymphopoietin
tslp
interact
group
innat
lymphoid
cell
also
recent
identifi
nagarkar
et
al
hong
et
al
allinn
et
al
tslp
type
inflammatori
cytokin
express
epitheli
cell
upon
injuri
epitheli
barrier
gabryelska
et
al
roan
et
al
group
lymphoid
cell
lack
b
cell
receptor
play
crucial
role
secret
type
cytokin
perpetu
type
inflamm
activ
scanlon
mckenzi
li
hendrik
event
viral
infect
cell
death
injuri
epitheli
barrier
also
induc
express
tslp
heighten
express
inflam
airway
allakhverdi
et
al
goldsmith
et
al
byer
et
al
shaw
et
al
beal
et
al
jackson
et
al
uller
persson
ravanetti
et
al
cytokin
work
concert
activ
secret
type
cytokin
aggrav
type
inflamm
airway
caus
acut
exacerb
camelo
et
al
case
copd
increas
activ
retain
capabl
differenti
may
also
augment
neutrophil
respons
aggrav
exacerb
silver
et
al
interestingli
factor
releas
great
extent
activ
respons
viral
infect
healthi
individu
yan
et
al
tan
et
al
despit
augment
type
exacerb
chronic
inflam
airway
jurak
et
al
classic
mechan
viral
induc
acut
exacerb
summar
figur
integr
virolog
microbiolog
immunolog
viral
infect
becom
interlink
addit
factor
figur
current
understand
viral
induc
exacerb
chronic
airway
inflammatori
diseas
upon
viru
infect
airway
antivir
state
activ
clear
invad
pathogen
airway
immun
respons
injuri
factor
releas
infect
epithelium
normal
would
induc
rapid
type
immun
facilit
viral
clearanc
howev
inflam
airway
cytokin
chemokin
releas
instead
augment
inflamm
present
chronic
inflam
airway
strengthen
neutrophil
infiltr
copd
airway
eosinophil
infiltr
asthmat
airway
effect
also
compound
particip
cell
copd
airway
cell
asthmat
airway
frontier
cell
development
biolog
wwwfrontiersinorg
mechan
implic
acut
exacerb
viral
infect
murray
et
al
murray
et
al
underlin
synergist
effect
viral
infect
sensit
agent
caus
sever
acut
exacerb
airway
especi
true
exacerb
event
occur
viral
infect
may
also
occur
well
viral
clearanc
kim
et
al
stolz
et
al
particular
late
onset
bacteri
infect
singanayagam
et
al
singanayagam
et
al
addit
virus
need
directli
infect
lower
airway
caus
acut
exacerb
nasal
epithelium
remain
primari
site
infect
moreov
viral
infect
airway
lead
acut
exacerb
suggest
complex
interplay
viru
upper
airway
epithelium
synerg
local
airway
environ
line
unit
airway
hypothesi
kurai
et
al
hand
viral
infect
compon
persist
patient
chronic
airway
inflammatori
diseas
kling
et
al
wood
et
al
ravi
et
al
henc
presenc
may
alter
local
environ
contribut
current
futur
exacerb
futur
studi
perform
use
metagenom
addit
pcr
analysi
determin
contribut
microbiom
mycobiom
viral
infect
review
highlight
recent
data
regard
viral
interact
airway
epithelium
could
also
contribut
aggrav
acut
exacerb
chronic
airway
inflammatori
diseas
patient
chronic
airway
inflammatori
diseas
impair
reduc
abil
viral
clearanc
hammond
et
al
mckendri
et
al
akbarshahi
et
al
gill
et
al
wang
et
al
singanayagam
et
al
impair
stem
type
inflammatori
respons
depriv
airway
import
type
respons
cell
respons
complet
clearanc
virusinfect
cell
becker
mckendri
et
al
especi
evid
weak
type
inflammationinduc
virus
rv
rsv
kling
et
al
wood
et
al
ravi
et
al
addit
also
evid
reduc
type
iii
interferon
product
due
type
inflamm
contribut
imperfect
clearanc
viru
result
persist
viral
compon
live
viru
airway
epithelium
contoli
et
al
hwang
et
al
wark
due
viral
compon
remain
airway
antivir
gene
type
interferon
inflammasom
activ
factor
cytokin
remain
activ
result
prolong
airway
inflamm
wood
et
al
essaidilaziosi
et
al
factor
enhanc
granulocyt
infiltr
thu
prolong
exacerb
symptom
persist
inflamm
may
also
found
within
dna
virus
adv
hcmv
hsv
whose
infect
gener
persist
longer
imperial
jiang
contribut
chronic
activ
inflamm
infect
airway
yang
et
al
morimoto
et
al
imperial
jiang
lan
et
al
tan
et
al
kowalski
et
al
note
human
papilloma
viru
hpv
dna
viru
highli
associ
head
neck
cancer
respiratori
papillomatosi
also
link
chronic
inflamm
preced
malign
de
visser
et
al
gillison
et
al
bonomi
et
al
fernand
et
al
therefor
role
hpv
infect
caus
chronic
inflamm
airway
associ
exacerb
chronic
airway
inflammatori
diseas
scarc
explor
investig
futur
furthermor
viral
persist
lead
continu
express
antivir
gene
may
also
lead
develop
steroid
resist
seen
rv
rsv
piv
infect
chi
et
al
ford
et
al
papi
et
al
use
steroid
suppress
inflamm
may
also
caus
viru
linger
longer
airway
due
lack
antivir
clearanc
kim
et
al
hammond
et
al
hewitt
et
al
mckendri
et
al
singanayagam
et
al
concomit
develop
steroid
resist
togeth
recur
prolong
viral
infect
thu
ad
consider
burden
manag
acut
exacerb
futur
focu
research
resolv
dual
complic
aris
viral
infect
end
spectrum
virus
induc
strong
type
inflamm
cell
death
ifv
yan
et
al
guiba
et
al
certain
cov
includ
recent
emerg
viru
tao
et
al
yue
et
al
zhu
et
al
may
caus
prolong
inflamm
due
strong
induct
antivir
clearanc
infect
howev
caus
massiv
damag
cell
death
epitheli
barrier
much
area
epithelium
may
complet
absent
post
infect
yan
et
al
tan
et
al
factor
rant
recruit
immun
cell
induc
apoptosi
strongli
induc
ifv
infect
epithelium
ampomah
et
al
tan
et
al
addit
necroptot
factor
compound
cell
death
ifv
infect
epithelium
massiv
cell
death
induc
may
result
worsen
acut
exacerb
due
releas
cellular
content
airway
evok
inflammatori
respons
airway
guiba
et
al
moreov
destruct
epitheli
barrier
may
caus
contact
pathogen
allergen
airway
may
prolong
exacerb
result
new
exacerb
epitheli
destruct
may
also
promot
epitheli
remodel
regener
viral
infect
induc
express
remodel
gene
mmp
growth
factor
infect
caus
massiv
destruct
epithelium
ifv
usual
result
sever
acut
exacerb
nonclass
symptom
chronic
airway
inflammatori
diseas
fortun
annual
vaccin
avail
prevent
ifv
infect
vasilei
et
al
zheng
et
al
recommend
patient
chronic
airway
inflammatori
diseas
receiv
annual
influenza
vaccin
best
mean
prevent
sever
ifv
induc
exacerb
anoth
mechan
viral
infect
may
use
drive
acut
exacerb
induct
vasodil
tight
junction
open
factor
may
increas
rate
infiltr
infect
multitud
respiratori
virus
caus
disrupt
tight
junction
result
increas
rate
viral
infiltr
also
increas
chanc
allergen
come
contact
airway
immun
cell
exampl
ifv
infect
found
induc
oncostatin
osm
caus
tight
junction
open
pothoven
et
al
tian
et
al
similarli
rv
rsv
infect
usual
caus
tight
junction
open
may
also
increas
infiltr
rate
eosinophil
thu
worsen
classic
symptom
chronic
airway
inflammatori
diseas
sajjan
et
al
kast
et
al
kim
et
al
addit
express
vasodil
factor
fluid
homeostat
factor
angiopoietinlik
bactericidalpermeabilityincreas
foldcontain
famili
member
also
associ
viral
infect
pneumonia
develop
may
worsen
inflamm
lower
airway
akram
et
al
factor
may
serv
target
prevent
viralinduc
exacerb
manag
acut
exacerb
chronic
airway
inflammatori
diseas
anoth
recent
area
interest
relationship
asthma
copd
exacerb
associ
airway
microbiom
develop
chronic
airway
inflammatori
diseas
usual
link
specif
bacteri
speci
microbiom
may
thrive
inflam
airway
environ
diver
et
al
event
viral
infect
rv
infect
effect
induc
viru
may
destabil
equilibrium
microbiom
present
molyneaux
et
al
kloepfer
et
al
kloepfer
et
al
jubinvil
et
al
van
rijn
et
al
addit
viral
infect
may
disrupt
biofilm
coloni
upper
airway
eg
streptococcu
pneumonia
microbiom
releas
lower
airway
worsen
inflamm
mark
et
al
chao
et
al
moreov
viral
infect
may
also
alter
nutrient
profil
airway
releas
previous
inaccess
nutrient
alter
bacteri
growth
siegel
et
al
mallia
et
al
furthermor
destabil
compound
impair
bacteri
immun
respons
either
direct
viral
influenc
use
corticosteroid
suppress
exacerb
symptom
singanayagam
et
al
singanayagam
et
al
wang
et
al
finney
et
al
may
gradual
lead
far
reach
effect
normal
flora
replac
opportunist
pathogen
alter
inflammatori
profil
teo
et
al
chang
may
turn
result
sever
frequent
acut
exacerb
due
interplay
viru
pathogen
bacteria
exacerb
chronic
airway
inflammatori
diseas
wark
et
al
singanayagam
et
al
counteract
effect
microbiomebas
therapi
infanc
shown
efficaci
treatment
irrit
bowel
syndrom
restor
intestin
microbiom
bakken
et
al
research
done
similarli
airway
microbiom
abl
restor
microbiom
follow
disrupt
viral
infect
viral
infect
caus
disrupt
mucociliari
function
import
compon
epitheli
barrier
ciliari
protein
figur
chang
upper
airway
epithelium
contribut
viral
exacerb
chronic
airway
inflammatori
diseas
upper
airway
epithelium
primari
contactinfect
site
respiratori
virus
therefor
infect
respiratori
virus
may
far
reach
consequ
augment
synerg
current
futur
acut
exacerb
destruct
epitheli
barrier
mucociliari
function
cell
death
epitheli
cell
serv
increas
contact
environment
trigger
lower
airway
resid
immun
cell
open
tight
junction
increas
leaki
augment
inflamm
exacerb
addit
viral
infect
usual
accompani
oxid
stress
increas
local
inflamm
airway
dysregul
inflamm
compound
modul
mirna
epigenet
modif
dna
methyl
histon
modif
promot
dysregul
inflamm
final
chang
local
airway
environ
inflamm
promot
growth
pathogen
bacteria
may
replac
airway
microbiom
furthermor
inflammatori
environ
may
also
dispers
upper
airway
commens
lower
airway
caus
inflamm
alter
lower
airway
environ
result
prolong
exacerb
episod
follow
viral
infect
viral
specif
trait
contribut
exacerb
mechan
literatur
evid
oxid
stress
ro
product
rv
rsv
ifv
hsv
rv
rsv
ifv
frequent
studi
virus
chronic
airway
inflammatori
diseas
virus
list
predominantli
virus
howev
mechan
state
may
also
applic
virus
may
list
implic
context
chronic
airway
inflammatori
diseas
exacerb
see
text
abbrevi
aid
proper
function
motil
cilia
airway
aberrantli
express
ciliat
airway
epitheli
cell
major
target
rv
infect
grigg
et
al
form
secondari
cilia
dyskinesia
appear
present
chronic
inflamm
airway
exact
mechan
still
unknown
peng
et
al
qiu
et
al
nevertheless
found
viral
infect
ifv
chang
metabol
cell
well
alter
ciliari
gene
express
mostli
form
downregul
gene
dynein
axonem
heavi
chain
multicili
differenti
dna
synthesi
associ
cell
cycl
protein
mcida
tan
et
al
recent
emerg
wuhan
cov
also
found
reduc
ciliari
beat
infect
airway
epitheli
cell
model
zhu
et
al
furthermor
viral
infect
rsv
shown
directli
destroy
cilia
ciliat
cell
almost
respiratori
virus
infect
ciliat
cell
jumat
et
al
yan
et
al
tan
et
al
addit
mucu
overproduct
may
also
disrupt
equilibrium
mucociliari
function
follow
viral
infect
result
symptom
acut
exacerb
zhu
et
al
henc
disrupt
ciliari
movement
viral
infect
may
caus
foreign
materi
allergen
enter
airway
aggrav
symptom
acut
exacerb
make
difficult
manag
mechan
occurr
secondari
cilia
dyskinesia
also
therefor
explor
mean
limit
effect
viral
induc
acut
exacerb
microrna
mirna
short
noncod
rna
involv
posttranscript
modul
biolog
process
implic
number
diseas
tan
et
al
mirna
found
induc
viral
infect
may
play
role
modul
antivir
respons
inflamm
gutierrez
et
al
deng
et
al
feng
et
al
case
chronic
airway
inflammatori
diseas
circul
mirna
chang
found
link
exacerb
diseas
wardzynska
et
al
therefor
like
mirna
chang
origin
infect
epithelium
respond
immun
cell
may
serv
dysregul
airway
inflamm
lead
exacerb
ifv
rsv
infect
shown
increas
augment
inflamm
experiment
murin
asthma
model
revers
combin
treatment
corticosteroid
kim
et
al
ifv
infect
also
shown
increas
b
copd
epithelium
inhibit
mav
respect
result
increas
suscept
viral
infect
hsu
et
al
hsu
et
al
convers
shown
suppress
asthmat
epithelium
ifv
infect
lead
aberr
epitheli
respons
contribut
exacerb
moheimani
et
al
direct
evid
mirna
chang
contribut
exacerb
increas
number
mirna
noncod
rna
respons
immun
modul
found
alter
follow
viral
infect
globinska
et
al
feng
et
al
hasegawa
et
al
henc
noncod
rna
also
present
target
modul
viral
induc
airway
chang
mean
manag
exacerb
chronic
airway
inflammatori
diseas
mirna
modul
epigenet
modif
dna
methyl
may
also
play
role
exacerb
chronic
airway
inflammatori
diseas
recent
epigenet
studi
indic
associ
epigenet
modif
chronic
airway
inflammatori
diseas
nasal
methylom
shown
sensit
marker
airway
inflammatori
chang
cardena
et
al
gomez
time
also
shown
viral
infect
rv
rsv
alter
dna
methyl
histon
modif
airway
epithelium
may
alter
inflammatori
respons
drive
chronic
airway
inflammatori
diseas
exacerb
mcerlean
et
al
pech
et
al
caixia
et
al
addit
spalluto
et
al
also
show
antivir
factor
epigenet
modifi
viral
resist
epitheli
cell
henc
may
indic
infect
rv
rsv
weakli
induc
antivir
respons
may
result
alter
inflammatori
state
contribut
viral
persist
exacerb
chronic
airway
inflammatori
diseas
spalluto
et
al
final
viral
infect
result
enhanc
product
reactiv
oxygen
speci
ro
oxid
stress
mitochondri
dysfunct
airway
epithelium
kim
et
al
mishra
et
al
wang
et
al
airway
epithelium
patient
chronic
airway
inflammatori
diseas
usual
state
constant
oxid
stress
sustain
inflamm
airway
barn
van
der
vliet
et
al
viral
infect
respiratori
epithelium
virus
ifv
rv
rsv
hsv
may
trigger
product
ro
antivir
mechan
aizawa
et
al
wang
et
al
moreov
infiltr
cell
respons
infect
neutrophil
also
trigger
respiratori
burst
mean
increas
ro
infect
region
increas
ro
oxid
stress
local
environ
may
serv
trigger
promot
inflamm
therebi
aggrav
inflamm
airway
tiwari
et
al
summari
potenti
exacerb
mechan
associ
virus
shown
figur
tabl
mechan
underli
develop
acut
exacerb
chronic
airway
inflammatori
diseas
extens
studi
way
manag
control
diseas
viral
infect
caus
acut
exacerb
patient
viralinduc
acut
exacerb
induc
worsen
symptom
diseas
also
may
alter
manag
diseas
confer
resist
toward
treatment
work
henc
appreci
mechan
viralinduc
acut
exacerb
clinic
signific
devis
strategi
correct
viral
induc
chang
may
worsen
chronic
airway
inflammatori
diseas
symptom
studi
natur
exacerb
viralchalleng
model
use
rnasequenc
rnaseq
singl
cell
rnaseq
rang
timepoint
may
provid
import
inform
regard
viral
pathogenesi
chang
induc
within
airway
chronic
airway
inflammatori
diseas
patient
identifi
novel
target
pathway
improv
manag
diseas
subsequ
analysi
function
may
use
epitheli
cell
model
airliquid
interfac
vitro
airway
epitheli
model
adapt
studi
viral
infect
chang
induc
airway
yan
et
al
boda
et
al
tan
et
al
animalbas
diseas
model
also
develop
identifi
system
mechan
acut
exacerb
shin
gubernatorova
et
al
tanner
singl
furthermor
human
mous
model
possess
human
immun
cell
may
also
serv
unravel
immun
profil
viral
infect
healthi
diseas
condit
ito
et
al
li
di
santo
milder
virus
control
vivo
human
infect
perform
best
mode
verif
associ
viru
propos
mechan
viral
induc
acut
exacerb
advent
suitabl
diseas
model
verif
mechan
provid
necessari
continu
improv
manag
viral
induc
acut
exacerb
conclus
viralinduc
acut
exacerb
chronic
airway
inflammatori
diseas
signific
health
econom
burden
need
address
urgent
view
scarciti
antiviralbas
prevent
measur
avail
virus
vaccin
avail
ifv
infect
altern
measur
explor
improv
manag
diseas
altern
measur
target
novel
viralinduc
acut
exacerb
mechan
especi
upper
airway
serv
supplementari
treatment
current
avail
manag
strategi
augment
efficaci
new
model
includ
primari
human
bronchial
nasal
epitheli
cell
cultur
organoid
precis
cut
lung
slice
patient
airway
diseas
rather
healthi
subject
util
defin
exacerb
mechan
mechan
valid
small
clinic
trial
patient
asthma
copd
multipl
mean
treatment
may
also
reduc
problem
aris
resist
develop
toward
specif
treatment
